Physician profile
Marla Roche
NPI 1932173952
$566.79
in general payments reported to CMS, 2019-2025
13 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $40.11 · 2022: $14.34 · 2023: $86.79 · 2024: $64.11 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $351.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $167.14 | 2019-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Pfizer INC. | $62.93 | 2019-2020 | |
| Tris Pharma INC | $62.82 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $52.48 | 2025 | Neffy |
| Galderma Laboratories, L.P. | $35.07 | 2025 | |
| Supernus Pharmaceuticals, INC. | $34.67 | 2022-2024 | Qelbree |
| Abbvie INC. | $34.05 | 2023 | Ubrelvy |
| Alk-Abello, INC | $28.13 | 2025 | Neffy |
| Sanofi-Aventis U.S. LLC | $26.34 | 2025 | |
| Sobi, INC | $19.17 | 2020 | |
| Ironshore Pharmaceuticals INC. | $16.99 | 2019 | |
| Sanofi Pasteur INC. | $14.39 | 2019 | |
| Kaleo, INC. | $12.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marla Roche listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.